Ohnhaus E E, Bürgi H, Burger A, Studer H
Eur J Clin Invest. 1981 Oct;11(5):381-7. doi: 10.1111/j.1365-2362.1981.tb02000.x.
The effect of three different live microsomal enzyme inducing drugs on thyroid hormone metabolism was investigated. Seven volunteers were randomly allocated in a crossover design to either antipyrine (1200 mg), phenobarbital (100 mg) or rifampicin (1200 mg) daily for 14 days. Before and after each treatment the following parameters of enzyme induction were measured: antipyrine clearance, gamma-glutamyltranspeptidase, d-glucaric acid and 6-beta-hydroxycortisol urinary excretion. In addition, thyroxine-binding globulin (TBG), T3-resin uptake (RT3U), thyroxine (T4), free thyroxine (FT4), triiodothyronine (T3), reverse T3 (rT3), and thyroid stimulating hormone were estimated. Following antipyrine and phenobarbital antipyrine clearance increased by about 45%, while with rifampicin an increase of 125% was observed. The indices of thyroid function did not change following phenobarbital and antipyrine, but after rifampicin T4, FT4 and rT3 decreased by about 14%, and T3 increased by 25%. In addition, the impact of rifampicin on the clearance of injected 125I-T4 was investigated in six additional volunteers by blocking thyroid iodine uptake. The 125I-T4 halflife decreased from 155 to 106 h and its clearance increased from 25 to 50 ml/h, while a fall in T4, FT4 and rT3 by about 40% and no rise but a decrease in T3 by 25% occurred. Therefore an increased clearance of T4 and rT3 but not of T3 seems likely following rifampicin, which might be due to enhanced hepatic metabolism and biliary excretion.
研究了三种不同的微粒体酶诱导活性药物对甲状腺激素代谢的影响。七名志愿者采用交叉设计,随机分配至每日服用安替比林(1200毫克)、苯巴比妥(100毫克)或利福平(1200毫克),持续14天。每次治疗前后,测量以下酶诱导参数:安替比林清除率、γ-谷氨酰转肽酶、d-葡萄糖醛酸和6-β-羟基皮质醇尿排泄量。此外,还评估了甲状腺素结合球蛋白(TBG)、T3树脂摄取率(RT3U)、甲状腺素(T4)、游离甲状腺素(FT4)、三碘甲状腺原氨酸(T3)、反三碘甲状腺原氨酸(rT3)和促甲状腺激素。服用安替比林和苯巴比妥后,安替比林清除率增加约45%,而服用利福平后,观察到清除率增加125%。苯巴比妥和安替比林治疗后甲状腺功能指标未发生变化,但服用利福平后,T4、FT4和rT3下降约14%,T3增加25%。此外,通过阻断甲状腺碘摄取,在另外六名志愿者中研究了利福平对注射的125I-T4清除率的影响。125I-T4半衰期从155小时降至106小时,其清除率从25毫升/小时增加至50毫升/小时,同时T4、FT4和rT3下降约40%,T3未升高反而下降25%。因此,服用利福平后,T4和rT3的清除率增加而T3未增加,这可能是由于肝脏代谢增强和胆汁排泄增加所致。